Inversago Pharma Inc.: Inversago Pharma Appoints Glenn S. Vraniak as Chief Financial Officer
Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak to the position of Chief Financial